MXCT Live signaler | Maksimer profitt med Getagraph.com

KJøP 120802 min ago

@ $4.78

Utstedt: 14 feb 2024 @ 18:00

Avkastning: 6.28%

Forrige signal: feb 13 - 16:49

Forrige signal: Selg

Avkastning: -0.46 %

Live Chart Being Loaded With Signals

Commentary (8 mai 2024 @ 16:22):

Stats
Dagens volum	1.21M
Gjennomsnittsvolum	550 827
Markedsverdi	530.96M
EPS	$0 ( 2024-05-07 )
Neste inntjeningsdato	( $0 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-13.73
ATR14	$0.0960 (1.90%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-26	Johnston John Joseph	Buy	5 000	Common Stock
2024-03-26	Johnston John Joseph	Sell	5 000	Common Stock
2024-03-26	Johnston John Joseph	Sell	5 000	Stock Option (right to buy)
2024-03-15	Ross Thomas M.	Buy	100 000	Employee Stock Option (right to buy)
2024-03-15	Ross Thomas M.	Buy	25 000	Common Stock

INSIDER POWER
40.24
Last 100 transactions
Buy: 1 609 082 \| Sell: 743 053

MaxCyte, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

MaxCyte, Inc. Økonomi

Annual	2023
Omsetning:	$41.29M
Bruttogevinst:	$32.56M (78.86 %)
EPS:	$-0.370

FY	2023
Omsetning:	$41.29M
Bruttogevinst:	$32.56M (78.86 %)
EPS:	$-0.370

FY	2022
Omsetning:	$44.26M
Bruttogevinst:	$39.16M (88.48 %)
EPS:	$-0.190

FY	2021
Omsetning:	$33.89M
Bruttogevinst:	$30.25M (89.24 %)
EPS:	$-0.210

Financial Reports:

No articles found.

MaxCyte, Inc.

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

Sanntidsoppdatering for MaxCyte, Inc. [MXCT]

Upcoming Earnings Alert